CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
non-inferiority to the HeartMate 3 Left Ventricular Assist System when used for the treatment of advanced, refractory, left ventricular heart...
Atlanta, Georgia, United States and 16 other locations
evaluating the safety and efficacy of dual chamber personalized pacing compared to minimal or no pacing for the treatment of patients with heart...
Atlanta, Georgia, United States and 4 other locations
This study is designed as a repository study to collect resting cardiac phase signals and subject meta data from eligible subjects using the...
Marietta, Georgia, United States of America and 16 other locations
) application in patients with symptomatic heart disease due to failure of a surgical or transcatheter bioprosthetic aortic valve w...
Atlanta, Georgia, United States and 66 other locations
A prospective, open label, multi-center, single arm, observational study designed to evaluate the acute safety and device performance of the Sapphire...
Atlanta, Georgia, United States and 13 other locations
have suggested that the addition of hormone therapy may worsen heart (cardiac) disease and high blood pressure. In fact, s...
Phase 3
Atlanta, Georgia, United States and 3 other locations
Prospective, single-arm, multi-center study to evaluate safety and effectiveness of the Autus Size-Adjustable Valve in pediatric patients aged 18 mon...
Atlanta, Georgia, United States and 11 other locations
PumpKIN is a multicenter, prospective, single-arm feasibility study; Evaluating the investigational Jarvik 2015 VAD in pediatric patients with heart...
Early Phase 1
Atlanta, Georgia, United States and 6 other locations
To assess the safety and effectiveness of the SAPIEN 3 transcatheter heart valve in patients with a failing mitral bioprosthetic valve....
Atlanta, Georgia, United States and 11 other locations
This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo...
Phase 3
Atlanta, Georgia, United States and 39 other locations
Clinical trials
Research sites
Resources
Legal